Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA -
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
Energy Researchers Aim For Holistic Approach to AI Issues
A new center at the Oak Ridge National Laboratory is looking at under-researched areas of AI to better understand how to secure it.
2m read -
How Agencies are Upskilling the Workforce in AI
Federal officials are putting in place new training and education methods to ensure its overall workforce understands the technology.
3m read -
Building Better Data Governance Across FDA
The agency is using emerging technology to tackle its data challenges.
19m listen -
Strategies for Effective Data Modernization
Data is the lifeblood of critical decisions and streamlines operations across the government, but many agencies struggle with inconsistent standards.
33m watch
